| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |